Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Aggarwal

Showing results (231-240 of 262) with videos related to

Pageof 27
Sort By:
Muscle & Nerve|July 23, 2022
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathiesAlbert Gil-Vila, Naveen Ravichandran, Albert Selva-O'Callaghan, et al.
Rheumatology (Oxford, England)|October 5, 2017
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspectsLisa G Rider, Nicolino Ruperto, Angela Pistorio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2017
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeLisa G Rider, Rohit Aggarwal, Angela Pistorio, et al.
International Journal of Rheumatic Diseases|March 5, 2023
Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD studySamuel Katsuyuki Shinjo, Minchul Kim, Leonardo Santos Hoff, et al.
Rheumatology International|September 5, 2023
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported surveySakir Ahmed, Latika Gupta, Masataka Kuwana, et al.
Rheumatology International|August 14, 2022
COVAD survey 2 long-term outcomes: unmet need and protocolZoha Zahid Fazal, Parikshit Sen, Mrudula Joshi, et al.
Arthritis Care & Research|March 6, 2026
Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome MeasuresDidem Saygin, Matthew Diller, Varsha Surampudi, et al.
International Journal of Rheumatic Diseases|May 14, 2024
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD groupRusska Shumnalieva, Naveen Ravichandran, Jennifer Hannah, et al.
Rheumatology Advances in Practice|March 25, 2024
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-surveyAkira Yoshida, Yuan Li, Vahed Maroufy, et al.
Rheumatology (Oxford, England)|April 26, 2025
Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS projectAnushka Aggarwal, Tanya Chandra, Shiri Keret, et al.
Pageof 27

Showing results (231-240 of 262) with videos related to

Sort By:
Pageof 27
Muscle & Nerve|July 23, 2022
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathiesAlbert Gil-Vila, Naveen Ravichandran, Albert Selva-O'Callaghan, et al.
Rheumatology (Oxford, England)|October 5, 2017
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspectsLisa G Rider, Nicolino Ruperto, Angela Pistorio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2017
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeLisa G Rider, Rohit Aggarwal, Angela Pistorio, et al.
International Journal of Rheumatic Diseases|March 5, 2023
Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD studySamuel Katsuyuki Shinjo, Minchul Kim, Leonardo Santos Hoff, et al.
Rheumatology International|September 5, 2023
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported surveySakir Ahmed, Latika Gupta, Masataka Kuwana, et al.
Rheumatology International|August 14, 2022
COVAD survey 2 long-term outcomes: unmet need and protocolZoha Zahid Fazal, Parikshit Sen, Mrudula Joshi, et al.
Arthritis Care & Research|March 6, 2026
Standardized Interoperable Data Collection for Myositis Research: Developing Expert Consensus on Common Data Elements for Myositis Outcome MeasuresDidem Saygin, Matthew Diller, Varsha Surampudi, et al.
International Journal of Rheumatic Diseases|May 14, 2024
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD groupRusska Shumnalieva, Naveen Ravichandran, Jennifer Hannah, et al.
Rheumatology Advances in Practice|March 25, 2024
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-surveyAkira Yoshida, Yuan Li, Vahed Maroufy, et al.
Rheumatology (Oxford, England)|April 26, 2025
Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS projectAnushka Aggarwal, Tanya Chandra, Shiri Keret, et al.
Pageof 27